Sort
261,768 grants matching “gene therapy”
Clonotyping Technology for Prediction of Antibiotic Resistance
$999,967Evgeni Veniaminovic Sokurenko · Idgenomics, Inc. · R42 · FY2016 · AI
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
$999,965Jay Edward Wrobel · Fox Chase Chemical Diversity Center, Inc · R44 · FY2021 · HL
Development of LNS8801 for cutaneous melanoma patients who cannot tolerate immunotherapy
$999,960Tina Garyantes · Linnaeus Therapeutics Inc · R44 · FY2025 · CA
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$999,953Abigail Pulsipher · Glycomira, Llc · R44 · FY2021 · AI
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)
$999,938Satish N Nadig · Northwestern University At Chicago · U01 · FY2023 · GM
Mechanistic Signatures of Drug Responses in Cancer
$999,932Timothy J Mitchison · Harvard Medical School · RC2 · FY2009 · HG
Novel IL-15 Superagonist Therapy for Bladder Cancer
$999,919John Lee · Altor Bioscience. Llc · R44 · FY2019 · CA
Novel IL-15 Superagonist Therapy for Bladder Cancer
$999,919Peter R Rhode · Altor Bioscience. Llc · R44 · FY2018 · CA
Novel IL-15 Superagonist Therapy for Bladder Cancer
$999,919Peter R Rhode · Altor Bioscience. Llc · R44 · FY2017 · CA
Novel Strategies to Clear Bacteria from the CF Lung
$999,919Saira Ahmad · Eldec Pharmaceuticals, Inc. · R44 · FY2022 · HL
Biased Agonism In GPCR Drug Discovery: Application To Somatostatin Agonists
$999,917Richard Scott Struthers · Crinetics Pharmaceuticals, Inc. · R44 · FY2013 · DK
Hemophilia Point-of-Care Monitoring Device and App
$999,888Eugene Yan-Ho Chan · Dna Medicine Institute · R44 · FY2024 · HL
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)
$999,859Satish N Nadig · Northwestern University At Chicago · U01 · FY2025 · GM
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)
$999,855Satish N Nadig · Northwestern University At Chicago · U01 · FY2024 · GM
Beginnings: Innovative, Immersive Training Program in Synthetic Biology and Biomanufacturing
$999,850Rana Khan · Hood College · · FY2025 · EDU
Development of a novel therapeutic for the treatment of diabetic nephropathy and renal fibrosis
$999,838Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2020 · DK
TARGETED STEM CELL-GENE THERAPY FOR INFLAMMATORY BRAIN DISEASE
$999,830Loma Linda University · · FY2011 · Department of Defense
Arizona Center for Education and Research on Therapeutics
$999,812Raymond L Woosley · Critical Path Institute · U18 · FY2009 · HS
Anal HPV Infection and ASIL in HIV+ and HIV- Women
$999,803University Of California San Francisco · R01 · FY2004 · CA
CENTER FOR CEREBROVASCULAR DISEASE
$999,789Stanford University · P01 · FY2002 · NS
Development of a protein drug for pancreatic cancer treatment
$999,780Zhi-Ren Liu · Proda Biotech, Llc · R42 · FY2018 · CA
Development of a protein drug for pancreatic cancer treatment
$999,780Zhi-Ren Liu · Proda Biotech, Llc · R42 · FY2019 · CA
FDT-BioTech: VAScTWIN: Multiscale Digital Twin for Predictive Modeling and Genetic Control of Cardiac Vascular Regeneration
$999,745Aishwarya R Pawar · Iowa State University · · FY2025 · MPS
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
$999,739Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2022 · AI
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity
$999,730Lisa Tussing-Humphreys · University Of Illinois At Chicago · R01 · FY2024 · CA